BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28062254)

  • 1. The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.
    Nesbit MO; Dias C; Phillips AG
    Behav Brain Res; 2017 Mar; 321():223-231. PubMed ID: 28062254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
    Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
    Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated BDNF mRNA expression in the medial prefrontal cortex after d-amphetamine reinstated conditioned place preference in rats.
    Shen YL; Chang TY; Chang YC; Tien HH; Yang FC; Wang PY; Liao RM
    Neuroscience; 2014 Mar; 263():88-95. PubMed ID: 24440750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabinoid CB₁ receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice.
    Yu LL; Zhou SJ; Wang XY; Liu JF; Xue YX; Jiang W; Lu L
    Behav Brain Res; 2011 Feb; 217(1):111-6. PubMed ID: 20937331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
    Häggkvist J; Lindholm S; Franck J
    Addict Biol; 2009 Jul; 14(3):260-9. PubMed ID: 19298318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core.
    Kobrin KL; Arena DT; Heinrichs SC; Nguyen OH; Kaplan GB
    Behav Brain Res; 2017 Mar; 322(Pt A):18-28. PubMed ID: 28089852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of D1- and D2-like dopamine receptors in the dentate gyrus in the acquisition, expression, and extinction of the morphine-induced conditioned place preference in rats.
    Katebi N; Farahimanesh S; Fatahi Z; Zarrabian S; Haghparast A
    Behav Brain Res; 2018 Nov; 353():185-193. PubMed ID: 30053460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitated extinction of morphine conditioned place preference with Tat-GluA2(3Y) interference peptide.
    Dias C; Wang YT; Phillips AG
    Behav Brain Res; 2012 Aug; 233(2):389-97. PubMed ID: 22633960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1- and D2-like dopamine receptors in the CA1 region of the hippocampus are involved in the acquisition and reinstatement of morphine-induced conditioned place preference.
    Assar N; Mahmoudi D; Farhoudian A; Farhadi MH; Fatahi Z; Haghparast A
    Behav Brain Res; 2016 Oct; 312():394-404. PubMed ID: 27374160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective dopamine D₃ receptor antagonist SB-277011A attenuates drug- or food-deprivation reactivation of expression of conditioned place preference for cocaine in male Sprague-Dawley rats.
    Ashby CR; Rice OV; Heidbreder CA; Gardner EL
    Synapse; 2015 Jun; 69(6):336-44. PubMed ID: 25851636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat.
    van der Kam EL; De Vry J; Tzschentke TM
    Eur J Pharmacol; 2009 Mar; 606(1-3):94-101. PubMed ID: 19210976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dopamine D1-like receptor within the nucleus accumbens in acute food deprivation- and drug priming-induced reinstatement of morphine seeking in rats.
    Sadeghzadeh F; Babapour V; Haghparast A
    Behav Brain Res; 2015; 287():172-81. PubMed ID: 25835321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
    Wang ZY; Guo LK; Han X; Song R; Dong GM; Ma CM; Wu N; Li J
    Behav Brain Res; 2021 Feb; 399():112971. PubMed ID: 33075396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference.
    Hsu E; Packard MG
    Neurobiol Learn Mem; 2008 May; 89(4):504-12. PubMed ID: 17905604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference.
    Islam F; Xu K; Beninger RJ
    Behav Brain Res; 2017 May; 326():217-225. PubMed ID: 28284949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA.
    García-Pardo MP; Escobar-Valero C; Rodríguez-Arias M; Miñarro J; Aguilar MA
    Behav Pharmacol; 2015 Aug; 26(5):411-7. PubMed ID: 25974188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reinstatement by cocaine and amphetamine of morphine-induced place preference in mice.
    Do Ribeiro Couto B; Aguilar MA; Rodríguez-Arias M; Miñarro J
    Behav Pharmacol; 2005 Jul; 16(4):253-9. PubMed ID: 15961965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats.
    Duarte C; Lefebvre C; Chaperon F; Hamon M; Thiébot MH
    Neuropsychopharmacology; 2003 Nov; 28(11):1903-15. PubMed ID: 12915863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.